Vanda Pharmaceuticals (VNDA) Asset Utilization Ratio (2011 - 2026)

Vanda Pharmaceuticals has reported Asset Utilization Ratio for 16 years, with the latest figure at 0.47 in Q1 2026.

• Quarterly Asset Utilization Ratio rose 51.03% year-over-year to 0.47 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.47 (up 51.03% YoY) and the FY2025 annual result came in at 0.38, up 23.86% from the prior year.
• Asset Utilization Ratio climbed to 0.47 in Q1 2026 per VNDA's latest filing, from 0.4 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.47 in Q1 2026 and troughed at 0.27 in Q1 2024.
• A 5-year average of 0.36 and a median of 0.35 in 2025 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2024 and 2026: Asset Utilization Ratio tumbled 32.0% in 2024, then jumped 51.03% in 2026.
• Over 5 years, Asset Utilization Ratio stood at 0.41 in 2022, then declined by 26.27% to 0.3 in 2023, then increased by 2.29% to 0.31 in 2024, then gained by 29.79% to 0.4 in 2025, then grew by 19.09% to 0.47 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.47, 0.4, and 0.35 for Q1 2026, Q4 2025, and Q3 2025 respectively.